CC BY 4.0 · World J Nucl Med
DOI: 10.1055/s-0045-1809053
Case Report

A Case of Lung Cancer Unexpectedly Detected with 99mTc (V)-DMSA Whole-Body/SPECT Imaging

Esmaeil Gharepapagh
1   Clinical Research Development Unit of Tabriz Valiasr Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
2   Department of Nuclear Medicine, Medical School, Tabriz University of Medical Sciences, Tabriz, Iran
,
Leila Namvar
3   Tuberculosis and Lung Disease Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
,
1   Clinical Research Development Unit of Tabriz Valiasr Hospital, Tabriz University of Medical Sciences, Tabriz, Iran
2   Department of Nuclear Medicine, Medical School, Tabriz University of Medical Sciences, Tabriz, Iran
› Institutsangaben

Abstract

In terms of cancer-related deaths, lung cancer is the most common type. To prevent this malignant and dangerous disease from progressing, early and differential diagnoses are very critical. A combination of dimercaptosuccinic acid and pentavalent 99mTc under alkaline conditions, 99mTc (V)-DMSA, can be used for malignant tumors' early diagnosis and prognosis. The 99mTc (V)-DMSA radiotracer is most commonly used for follow-up of medullary thyroid cancer metastases, but it is also successful in lung cancer and other malignancies. In this case, a 65-year-old woman with a recent history of nonproductive cough and mild dyspnea and suspicious small masses of lungs in computed tomography was selected for imaging with 99mTc (V)-DMSA to evaluate the condition of radiotracer uptake in the lung masses. The whole-body and single-photon emission computed tomography imaging with semiquantitative analysis showed abnormal uptakes in the lesions and the patient underwent to transbronchial biopsy and bronchial washing cytology that confirmed non-small cell lung cancer.



Publikationsverlauf

Artikel online veröffentlicht:
06. Mai 2025

© 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 
  • References

  • 1 Sung H, Ferlay J, Siegel RL. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71 (03) 209-249
  • 2 Wong MCS, Lao XQ, Ho KF, Goggins WB, Tse SLA. Incidence and mortality of lung cancer: global trends and association with socioeconomic status. Sci Rep 2017; 7 (01) 14300
  • 3 Wood DE. National Comprehensive Cancer Network (NCCN) clinical practice guidelines for lung cancer screening. Thorac Surg Clin 2015; 25 (02) 185-197
  • 4 Manafi-Farid R, Askari E, Shiri I. et al. [18F]FDG-PET/CT Radiomics and Artificial Intelligence in Lung Cancer: Technical Aspects and Potential Clinical Applications. Semin Nucl Med 2022; 52 (06) 759-780
  • 5 Delgado Bolton RC, Calapaquí-Terán AK, Giammarile F, Rubello D. Role of 18F-FDG PET/CT in establishing new clinical and therapeutic modalities in lung cancer. A short review. Rev Esp Med Nucl Imagen Mol (Engl Ed) 2019; 38 (04) 229-233
  • 6 Shukla J, Mittal BR. Dimercaptosuccinic acid: a multifunctional cost effective agent for imaging and therapy. Indian J Nucl Med 2015; 30 (04) 295-302
  • 7 Ullah H. et al. In-house preparation of pentavalent 99mTc labeled dimercaptosuccinic acid [99mTc (V)-DMSA], its quality control and clinical applications. Pakistan J Nuclear Med 2019; 8 (01) 31-37
  • 8 Abdelhafez YG. et al. Diagnostic value of posttherapy brain single photon emission computed tomography/computed tomography with pentavalent 99mTc dimercaptosuccinic acid in patients with glioblastoma multiform: preliminary report. J Curr Med Res Pract 2019; 4 (03) 296
  • 9 Kandathil A, Sibley III RC, Subramaniam RM. Lung cancer recurrence: 18F-FDG PET/CT in clinical practice. AJR Am J Roentgenol 2019; 213 (05) 1136-1144
  • 10 Rezaei S, Ghafarian P, Jha AK, Rahmim A, Sarkar S, Ay MR. Joint compensation of motion and partial volume effects by iterative deconvolution incorporating wavelet-based denoising in oncologic PET/CT imaging. Phys Med 2019; 68: 52-60
  • 11 Treglia G, Rufini V, Piccardo A, Imperiale A. Update on Management of Medullary Thyroid Carcinoma: Focus on Nuclear Medicine. Semin Nucl Med 2023; 53 (04) 481-489
  • 12 Papantoniou V, Valsamaki P, Sotiropoulou E. et al. Increased breast density correlates with the proliferation-seeking radiotracer (99m)Tc(V)-DMSA uptake in florid epithelial hyperplasia and in mixed ductal carcinoma in situ with invasive ductal carcinoma but not in pure invasive ductal carcinoma or in mild epithelial hyperplasia. Mol Imaging 2011; 10 (05) 370-376
  • 13 Kao CH, Wang SJ, Wey SP, Shen LH, Ting G, Yeh SH. Using technetium-99m (V) dimercaptosuccinic acid to detect malignancies from single solid masses in the lungs. Eur J Nucl Med 1992; 19 (10) 890-893
  • 14 Kulkarni SC, Murthy SP. Nuclear medicine in head and neck cancer. In: Subramaniam N, Vidhyadharan S, Murthy SP. eds. Comprehensive management of head and neck cancer. 2021. New Delhi, India: Jaypee Brothers Medical Publishers; p. 430
  • 15 Iglesias P, Cardona J, Díez JJ. The pituitary in nuclear medicine imaging. Eur J Intern Med 2019; 68: 6-12
  • 16 Kovacsne A, Kozon I, Bentestuen M, Zacho HD. Frequency of superscan on bone scintigraphy: a systematic review. Clin Physiol Funct Imaging 2023; 43 (05) 297-304
  • 17 Sintya E. Synthesis of 99mtc (V)-DMSA and radiolabelling of SPIO nanoparticles. in IOP Conference Series: Materials Science and Engineering. 2018. IOP Publishing.
  • 18 Weinberg RA. Mechanisms of malignant progression. Carcinogenesis 2008; 29 (06) 1092-1095
  • 19 Blower PJ, Singh J, Clarke SE. The chemical identity of pentavalent technetium-99m-dimercaptosuccinic acid. J Nucl Med 1991; 32 (05) 845-849
  • 20 Yokoyama A, Hata N, Horiuchi K. et al. The design of a pentavalent 99mTc-dimercaptosuccinate complex as a tumor imaging agent. Int J Nucl Med Biol 1985; 12 (04) 273-279
  • 21 Zierler K. Whole body glucose metabolism. Am J Physiol 1999; 276 (03) E409-E426